Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study.
The anticryptosporidial activity of paromomycin, a natural antibiotic weakly absorbed when administered per os, was assessed in goat kids experimentally infected once via the oral route with 10(6) Cryptosporidium parvum oocysts. Paromomycin used prophylactically at a dose of 100 mg/kg of body weight per day from day-1 to day 10 (day 0 was the inoculation day) prevented infection during the period of drug administration. A delayed low infection was suggested by an antibody rise, but the infection developed below the microscopic detection limits. This low parasite development induced a partial immunity in kids, which reacted immunologically to a challenge on day 21 without symptoms or detectable oocyst shedding. So, paromomycin is a good candidate for field trials because it is prophylactically effective against experimental C. parvum infection and well tolerated by animals. This drug would be useful in an adapted form as an anticryptosporidial agent for neonatal ruminants.
Mancassola
R
R
Station de Pathologie Aviaire et de Parasitologie, Institut National de la Recherche Agronomique, Nouzilly, France.
Reperant
J M
JM
Naciri
M
M
Chartier
C
C
D000818:Animals; D000913:Antibodies, Protozoan / Q000187:drug effects; D003457:Cryptosporidiosis / Q000276:immunology / Q000517:prevention & control*; D016785:Cryptosporidium parvum / Q000254:growth & development / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006041:Goats; D008297:Male; D010303:Paromomycin / Q000627:therapeutic use*
D000913:Antibodies, Protozoan; D010303:Paromomycin